Yvonne Bager

Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains.

Matti Viluksela, Yvonne Bager, Jouni T. Tuomisto et al. · PubMed · 2000 · 109 citations

Pathology, Pharmacotherapy, Dioxin-induced Carcinogenesis +21

Liver tumour promoting activity of 3,4,5,3′,4′-pentachlorobiphenyl and its interaction with 2,3,7,8-tetrachlorodibenzo-p-dioxin

H. G. Hemming, Yvonne Bager, Sten Flodström et al. · European Journal of Pharmacology Environmental Toxicology and Pharmacology · 1995 · 29 citations

Oncology, Hepatology, Medicine +11

Alteration in expression of gap junction proteins in rat liver after treatment with the tumour promoter 3,4,5,3′,4′-pentachiorobiphenyl

Yvonne Bager, Kerstin Kenne, Vladimir Krutovskikh et al. · Carcinogenesis · 1994 · 22 citations

Altered function, localization and phosphorylation of gap junctions in rat liver epithelial, IAR 20, cells after treatment with PCBs or TCDD

Yvonne Bager, Maria C Lindebro, Paule Latino‐Martel et al. · Environmental Toxicology and Pharmacology · 1997 · 22 citations

Iar 20, Signal Transduction, Hepatology +12

The ability to alter the gap junction protein expression outside GST-P positive foci in liver of rats was associated to the tumour promotion potency of different polychlorinated biphenyls

Yvonne Bager, Yoshihisa Kato, Kerstin Kenne et al. · Chemico-Biological Interactions · 1997 · 22 citations

Tumour Promotion Potency, Oncogenic Agent, Medicine +9